Search research articles
Contact Us
Filters
Showing results (151-160 of 154) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 154 results.
Science Advances
|
August 12, 2021
Efficient derivation of human trophoblast stem cells from primed pluripotent stem cells
Yanxing Wei, Tianyu Wang, Lishi Ma, et al.
Cell Host & Microbe
|
June 16, 2023
Effects of vaginal microbiota transfer on the neurodevelopment and microbiome of cesarean-born infants: A blinded randomized controlled trial
Lepeng Zhou, Wen Qiu, Jie Wang, et al.
The Journal of Infection
|
May 28, 2021
Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study
Yaoju Tan, Yunfeng Deng, Xiaofeng Yan, et al.
Journal of Clinical and Translational Hepatology
|
October 15, 2019
Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China
Xiaoyuan Xu, Bo Feng, Yujuan Guan, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 154) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 154 results.
Science Advances
|
August 12, 2021
Efficient derivation of human trophoblast stem cells from primed pluripotent stem cells
Yanxing Wei, Tianyu Wang, Lishi Ma, et al.
Cell Host & Microbe
|
June 16, 2023
Effects of vaginal microbiota transfer on the neurodevelopment and microbiome of cesarean-born infants: A blinded randomized controlled trial
Lepeng Zhou, Wen Qiu, Jie Wang, et al.
The Journal of Infection
|
May 28, 2021
Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study
Yaoju Tan, Yunfeng Deng, Xiaofeng Yan, et al.
Journal of Clinical and Translational Hepatology
|
October 15, 2019
Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China
Xiaoyuan Xu, Bo Feng, Yujuan Guan, et al.
Page
of 16